Epigenetic Modifications in Acute Myeloid Leukemia: Prognosis, Treatment, and Heterogeneity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Epigenetic Modifications in Acute Myeloid Leukemia: Prognosis, Treatment, and Heterogeneity

Published:2019-03-01 Issue: Volume:10 Page:
ISSN:1664-8021
Container-title:Frontiers in Genetics
language:
Short-container-title:Front. Genet.

Author:

Goldman Samantha L.,Hassan Ciaran,Khunte Mihir,Soldatenko Arielle,Jong Yunji,Afshinnekoo Ebrahim,Mason Christopher E.

Funder

NASA

National Institutes of Health

Bill and Melinda Gates Foundation

Leukemia and Lymphoma Society

Publisher

Frontiers Media SA

Subject

Genetics (clinical),Genetics,Molecular Medicine

Reference182 articles.

1. Epigenetic therapy in a new era of medicine: creating and integrating molecular profiles of patients;Afshinnekoo;Ann. Transl. Med.,2016

2. Long non-coding RNAs discriminate the stages and gene regulatory states of human humoral immune response;Agirre,2018

3. The C/EBP tumor suppressor is silenced by hypermethylation in acute myeloid leukemia;Agrawal;Blood,2007

4. The molecular hallmarks of epigenetic control;Allis;Nat. Rev. Genet.,2016

5. The role of a Runt domain transcription factor AML1/RUNX1 in leukemogenesis and its clinical implications;Asou;Crit. Rev. Oncol. Hematol.,2003

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, and biological activity evaluation of novel HDAC3 selective inhibitors for combination with Venetoclax against acute myeloid leukemia;European Journal of Medicinal Chemistry;2024-10

2. Exploration of the mechanism of fraxetin in treating acute myeloid leukemia based on network pharmacology and experimental verification;Heliyon;2024-08

3. The type of DNA damage response after decitabine treatment depends on the level of DNMT activity;Life Science Alliance;2024-06-21

4. The impact of COVID-19 on microRNA and CD marker expression in AML patients;Scientific Reports;2024-06-20

5. Discovery of JNJ-74856665: A Novel Isoquinolinone DHODH Inhibitor for the Treatment of AML;Journal of Medicinal Chemistry;2024-06-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3